Amzak Health is an evergreen healthcare investment fund and the healthcare investment arm of Amzak Capital Management, the private investment firm of the Kazma family. Based in New York City, the firm invests in first-in-class and best-in-class medtech and biotech companies, supporting portfolio companies throughout their lifecycle from early-stage through commercialization.
Deal activity decreased year-over-year (1 deal in the last 12 months vs 4 prior). Their most common stage is series-a (42% of deals). Average disclosed round size is $59.4M (across 23 rounds with reported amounts).
Portfolio
15
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
24 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Nervonik | Series B | $52.5M | Apr 2026 |
 Neuros Medical | Series D | $56M | Jul 2025 |
 Neuros | Series D | $56M | Jul 2025 |
 Reneo | Series B | $47.3M | Feb 2025 |
| SSound Blade Medical | Series A | $16.5M | Jan 2025 |
| Neuros | Series A | $56M | Jan 2025 |
| SSynergy Spine Solutions | Series A | $30M | Jan 2024 |
 ShiraTronics, Inc | Series B | $66M | Jan 2024 |
| SSynergy Spine | Series A | $30M | Jan 2024 |
 Miach Orthopaedics | Bridge | — | Jan 2023 |
| ShiraTronics, Inc | Series A | $3M | Jan 2023 |
 Histosonics | Series D | $85M | Dec 2022 |
| AAntios Therapeutics, Inc. | Series B | $75M | Nov 2021 |
| AAntios Therapeutics, Inc. | Series A | $75M | Nov 2021 |
 Thryv Therapeutics | Series A | $19M | Aug 2021 |
| AAntios Therapeutics, Inc. | Series B | $96M | Apr 2021 |
| Neuros Medical | Series A | $38.5M | Jan 2021 |
| AAntios Therapeutics, Inc. | Series B | $96M | Jan 2021 |
| RReneo Pharmaceuticals Inc | Series B | $95M | Dec 2020 |
| Reneo | Series A | $95M | Dec 2020 |
| Reneo | Series B | $95M | Dec 2020 |
 4DMT | Series C | $75M | Jun 2020 |
| ShiraTronics, Inc | Series A | $33M | Oct 2019 |
 4D Molecular Therapeutics | Series C | $75M | — |
Top Co-Investors
Aperture Venture Partners7 shared
U.S. Venture Partners6 shared
Sectoral Asset Management5 shared
Pontifax4 shared
Delos Capital4 shared
Sixty Degree Capital4 shared
LifeSci Venture Partners4 shared
Soleus Capital4 shared
RA Capital Management4 shared
Osage University Partners4 shared
New Enterprise Associates4 shared
RiverVest Venture Partners4 shared
Pappas Capital4 shared
Abingworth LLP4 shared
Novo Capital4 shared
Rock Springs Capital4 shared
Adage Capital Management3 shared
EQT Life Sciences3 shared
Domain Associates3 shared
Realty Corporation3 shared
Last updated: 20 October 2026